City of Munich Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2002
NCT00268814
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Institut für Allgemeinmedizin, LMU München

Active Ingredients

Drugs in Phase 3 Trials (2)

diacetylmorphine (1 trial)

methadone (methadose) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2